Private Equity Deal Spotlight | Weekly Update

Health care continues to drive private equity (“PE”) activity, creating opportunities for investors and traditional health care providers. Transactions in the health care space are especially complicated, layering health care regulatory and reimbursement considerations on top of a complex securities, antitrust, privacy and security framework.

Hall Render’s PE team of attorneys and advisors leverage the strength and depth of our bench to navigate and efficiently execute PE transactions. The summary below includes highlights of recent PE deals and legislative updates.

• Knipper Health, backed by Frazier Healthcare Partners, recently announced the acquisition of eBlu Solutions. eBlue Solutions offers an integrated technology platform that provides real-time medical and pharmacy benefit investigations, electronic prior authorizations and digital patient access enrollment. The addition of eBlu Solutions enhances Knipper Health’s capabilities by introducing an industry-leading platform for order and therapy initiation. Frazier Healthcare Partners is a PE firm headquartered in Seattle, Washington, that focuses investments exclusively within the health care industry.
• NextPhase Capital recently announced the acquisition of Empower Community Care. Empower Community Care is a behavioral health enablement platform that provides evidence-based services and software to support communities and currently serves more than 2,000 customers across all 50 states and 35 countries. NextPhase Capital is a lower middle-market PE firm based in New York, New York that invests largely in the health care, software and consumer verticals. NextPhase currently manages approximately $2.6 billion in capital.
• Sellers Dorsey, backed by Consonance Capital Partners, recently acquired DignifiHealth. DignifiHealth specializes in population health and value-based care data analytics. Specifically, DignifiHealth partners with health care organizations across the country to translate data into improved patient outcomes and reduced costs. The acquisition marks the latest step for Seller Dorsey in an effort to create an integrated health care impact platform. Consonance Capital Partners is a PE firm headquartered in New York, New York, that focuses investments throughout the health care industry.
• Summit Partners recently announced a growth investment in Dreampath Diagnostics. Dreampath Diagnostics is a leading health care technology company that works to digitize workflows in anatomical pathology laboratories. Following the investment, Dreampath Diagnostics intends to accelerate its global growth, scale operations and expand its commercial reach and product portfolio. Summit Partners is a PE firm based in Boston, Massachusetts that invests largely in technology, health care, life sciences and other growth industries.

For questions or additional information on private equity matters, please contact: